Purple Biotech (XTAE:PPBT) Ending Cash Position : ₪37.41 Mil (As of Mar. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Ending Cash Position?

Purple Biotech's Ending Cash Position for the quarter that ended in Mar. 2024 was ₪37.41 Mil.

Purple Biotech's quarterly Ending Cash Position declined from Sep. 2023 (₪56.59 Mil) to Dec. 2023 (₪54.28 Mil) and declined from Dec. 2023 (₪54.28 Mil) to Mar. 2024 (₪37.41 Mil).

Purple Biotech's annual Ending Cash Position increased from Dec. 2021 (₪40.80 Mil) to Dec. 2022 (₪56.31 Mil) but then declined from Dec. 2022 (₪56.31 Mil) to Dec. 2023 (₪54.28 Mil).

Purple Biotech Ending Cash Position Historical Data

The historical data trend for Purple Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Ending Cash Position Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

16.43

42.14

40.80

56.31

54.28

Purple Biotech Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															81.99	64.45	56.59	54.28	37.41

Purple Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Purple Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	56.31	+	-2.027
	=	54.28

Purple Biotech's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	54.283	+	-16.874
	=	37.41

Purple Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.